Leading CRAC Channel Platform Company Delivering Drug Candidates For Inflammatory Diseases
CRAC Channel Technology
Calcium release-activated calcium channels, or CRAC channels, are responsible for replenishing the calcium stores inside many cell types. Since calcium is an important regulator of multiple biological functions, CRAC channel activation controls several of these functions including inflammation, vascular permeability and cell death.
Auxora Pipeline
CalciMedica is advancing their lead product candidate AuxoraTM for the treatment of acute inflammatory conditions such as acute pancreatitis and COVID-19 pneumonia.
News
CalciMedica Announces Publication of Results from CARDEA COVID-19 Study in Critical Care
– Results further support therapeutic potential of Auxora in respiratory diseases and other inflammatory diseases – LA JOLLA, Calif., April 14, 2022 – CalciMedica Inc. (CalciMedica …
CalciMedica Announces Publication of Peer-Reviewed Paper in The Journal of Physiology
Study Supports Development of CRAC Channel Inhibitors for Acute Pancreatitis Study indicates that Orai1 inhibition prevents impaired ductal cell function in acute pancreatitis (AP) Data …